Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB26FATEP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On October 24, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120 count). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected through firm fixed-price procurement with no set-aside designation, indicating competitive award among unrestricted bidders. The delivery order has an ultimate completion date of October 27, 2025, with performance to occur at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling value through December 31, 2036. The PPV-G GEN V represents part of the DLA's broader $30.3 billion pharmaceutical acquisition strategy designed to ensure a consistent supply of branded and generic prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. As a critical regional prime vendor contractor, DMS Pharmaceutical Group supplies specialized pharmaceutical products, including oncology treatments and specialty medications, to support global military medical operations.
Quick answers
Who was awarded contract SPE2DB26FATEP?
SPE2DB26FATEP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FATEP worth?
The government has obligated $4,170 on SPE2DB26FATEP.
Is contract SPE2DB26FATEP an order under another contract?
Yes. SPE2DB26FATEP is a delivery order under SPE2DB24D9228, an indefinite delivery contract.
Was contract SPE2DB26FATEP competed?
The extent of competition for SPE2DB26FATEP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award